Use of Statins and Blood Pressure

American Journal of Hypertension

Volumn 20, Issue 9, 2007, Pages 937-941

  King, Dana E ^a   Mainous III, Arch G ^a   Egan, Brent M ^a   Player, Marty ^a   Geesey, Mark E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

blood pressure; C reactive protein; hypertension; inflammation; Statins

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CERIVASTATIN; FLUINDOSTATIN; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; EXERCISE; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SODIUM RESTRICTION;

BLOOD PRESSURE; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 34548180739     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2007.03.018     Document Type: Article

References (17)

1. Boos C.J., and Lip G.Y. Is hypertension an inflammatory process?. Curr Pharm Des 12 (2006) 1623-1635
2. Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., and Ridker P.M. C-reactive protein and the risk of developing hypertension. JAMA 290 (2003) 2945-2951
3. King D.E., Egan B.M., Mainous III A.G., and Geesey M.E. Elevation of C-reactive protein in people with hypertension. J Clin Hypertens 6 (2004) 562-528
4. Thomas M.K., Narang D., Lakshmy R., Gupta R., Naik N., and Maulik S.K. Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients "on" and "off" atorvastatin for short time intervals. Cardiovasc Drugs Ther 20 (2006) 37-44
5. Kanbay M., Yldirir A., Bozbas H., Ulus T., Bilgi M., Muderrisoglu H., Akcay A., and Ozdemir F.N. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Ren Fail 27 (2005) 297-303
6. Magen E., Viskoper R., Michal J., Priluk R., Berezovsky A., Laszt A., London D., and Yosefy C. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control. Isr Med Assoc J 6 (2004) 742-746
7. Pearson T.A., Mensah G.A., Alexander R.W., Anderson A.L., Cannon III R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hony Y., Myers G.L., Rifai N., Smith Jr. S.C., Taubert K., Tracy R.P., and Vinicor F. AHA/CDC scientific statement. Markers of inflammation and cardiovascular disease. Circulation 107 (2003) 499-511
8. Milionis H.J., Liberopoulos E.N., Achimastos A., Elisaf M.S., and Mikhalidis D.P. Statins: another class of antihypertensive agents?. J Hum Hypertens 20 (2006) 320-335
9. Borghi C., Dormi A., Veronesi M., Sangiorgi Z., Gaddi A., and Brisighella Heart Study Working Party. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J 148 (2004) 285-292
10. Glorioso N., Troffa C., Filigheddu F., Dettori F., Soro A., Parpaglia P.P., Collatina S., and Pahor M. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 34 (1999) 1281-1286
11. Sartor G., Katzman P., Eizyk E., Kalen J., Nilsson A., Ugander L., and Ursing D. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus. Int J Clin Pharmacol Ther 33 (1995) 3-6
12. Antonicelli R., Onorato G., Pagelli P., Pierazzoli L., and Paciaroni E. Simvastatin in the treatment of hypercholesterolemia in elderly patients. Clin Ther 12 (1990) 165-171
13. D'Agostino R.B., Kannel W.B., Stepanians M.N., and D'Agostino L.C. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension. Am J Cardiol 71 (1993) 82-87
14. Ichihara A., Hayashi M., Koura Y., Tada U., Kaneshiro Y., and Saruta T. Long-term effects of statins on arterial pressure and stiffness of hypertensives. J Hum Hypertens 19 (2005) 103-109
15. Schillaci G., and Pirro M. C-reactive protein in hypertension: clinical significance and predictive value. Nutr Metab Cardiovasc Dis 16 (2006) 500-508
16. Endres M. Statins: potential new indications in inflammatory conditions. Atherosclerosis 7 Suppl (2006) 31-35
17. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith Jr. S.C., Taubert K., Tracy R.P., Vinicor F., Centers for Disease Control and Prevention, and American Heart Association. AHA/CDC scientific statement. Markers of inflammation and cardiovascular disease-application to clinical and public health practice. Circulation 107 (2003) 499-511